<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240403203928&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240403203928&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Thu, 04 Apr 2024 00:39:32 +0000</lastbuilddate>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Cardio-obstetrics: a new specialty</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38569057/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 3:ehae202. doi: 10.1093/eurheartj/ehae202. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38569057/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38569057</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae202>10.1093/eurheartj/ehae202</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38569057</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Eugene Braunwald</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardio-obstetrics: a new specialty</dc:title>
<dc:identifier>pmid:38569057</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae202</dc:identifier>
</item>
<item>
<title>Intravascular Imaging-Guided Optimization of Complex Percutaneous Coronary Intervention by Sex: A Subgroup Analysis of the RENOVATE-COMPLEX-PCI Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38568686/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: In patients undergoing complex PCI, compared with angiographic guidance, intravascular imaging guidance was associated with similar reduction in the risk of target vessel failure among women and men. The treatment benefit of intravascular imaging-guided PCI showed no significant interaction between treatment strategy and sex.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Apr 3. doi: 10.1001/jamacardio.2024.0291. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: There have been heterogeneous results related to sex differences in prognosis after percutaneous coronary artery intervention (PCI) for complex coronary artery lesions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate potential differences in outcomes with intravascular imaging-guided PCI of complex coronary artery lesions between women and men.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This prespecified substudy evaluates the interaction of sex in the investigator-initiated, open-label, multicenter RENOVATE-COMPLEX-PCI randomized clinical trial, which demonstrated the superiority of intravascular imaging-guided PCI compared with angiography-guided PCI in patients with complex coronary artery lesions. The trial was conducted at 20 sites in Korea. Patients with complex coronary artery lesions undergoing PCI were enrolled between May 2018 and May 2021, and the median (IQR) follow-up period was 2.1 (1.4-3.0) years. Data were analyzed from December 2022 to December 2023.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTIONS: After diagnostic coronary angiography, eligible patients were randomly assigned in a 2:1 ratio to receive intravascular imaging-guided PCI or angiography-guided PCI. The choice and timing of the intravascular imaging device were left to the operators' discretion.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary end point was target vessel failure, defined as a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization. Secondary end points included individual components of the primary end point.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 1639 included patients, 339 (20.7%) were women, and the mean (SD) age was 65.6 (10.2) years. There was no difference in the risk of the primary end point between women and men (9.4% vs 8.3%; adjusted hazard ratio [HR], 1.39; 95% CI, 0.89-2.18; P = .15). Intravascular imaging-guided PCI tended to have lower incidence of the primary end point than angiography-guided PCI in both women (5.2% vs 14.5%; adjusted HR, 0.34; 95% CI, 0.15-0.78; P = .01) and men (8.3% vs 11.7%; adjusted HR, 0.72; 95% CI, 0.49-1.05; P = .09) without significant interaction (P for interaction = .86).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: In patients undergoing complex PCI, compared with angiographic guidance, intravascular imaging guidance was associated with similar reduction in the risk of target vessel failure among women and men. The treatment benefit of intravascular imaging-guided PCI showed no significant interaction between treatment strategy and sex.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03381872.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38568686/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38568686</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0291>10.1001/jamacardio.2024.0291</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38568686</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Ji Hyun Cha</dc:creator>
<dc:creator>Joo Myung Lee</dc:creator>
<dc:creator>Ki Hong Choi</dc:creator>
<dc:creator>Jong-Young Lee</dc:creator>
<dc:creator>Seung-Jae Lee</dc:creator>
<dc:creator>Sang Yeub Lee</dc:creator>
<dc:creator>Sang Min Kim</dc:creator>
<dc:creator>Kyeong Ho Yun</dc:creator>
<dc:creator>Jae Young Cho</dc:creator>
<dc:creator>Chan Joon Kim</dc:creator>
<dc:creator>Hyo-Suk Ahn</dc:creator>
<dc:creator>Chang-Wook Nam</dc:creator>
<dc:creator>Hyuck-Jun Yoon</dc:creator>
<dc:creator>Yong Hwan Park</dc:creator>
<dc:creator>Jin-Ok Jeong</dc:creator>
<dc:creator>Pil Sang Song</dc:creator>
<dc:creator>Joon-Hyung Doh</dc:creator>
<dc:creator>Sang-Ho Jo</dc:creator>
<dc:creator>Chang-Hwan Yoon</dc:creator>
<dc:creator>Min Gyu Kang</dc:creator>
<dc:creator>Jin-Sin Koh</dc:creator>
<dc:creator>Kwan Yong Lee</dc:creator>
<dc:creator>Young-Hyo Lim</dc:creator>
<dc:creator>Yun-Hyeong Cho</dc:creator>
<dc:creator>Jin-Man Cho</dc:creator>
<dc:creator>Woo Jin Jang</dc:creator>
<dc:creator>Kook-Jin Chun</dc:creator>
<dc:creator>David Hong</dc:creator>
<dc:creator>Taek Kyu Park</dc:creator>
<dc:creator>Jeong Hoon Yang</dc:creator>
<dc:creator>Seung-Hyuk Choi</dc:creator>
<dc:creator>Hyeon-Cheol Gwon</dc:creator>
<dc:creator>Joo-Yong Hahn</dc:creator>
<dc:creator>Wang Soo Lee</dc:creator>
<dc:creator>Young Bin Song</dc:creator>
<dc:creator>RENOVATE-COMPLEX-PCI Investigators</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Intravascular Imaging-Guided Optimization of Complex Percutaneous Coronary Intervention by Sex: A Subgroup Analysis of the RENOVATE-COMPLEX-PCI Trial</dc:title>
<dc:identifier>pmid:38568686</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0291</dc:identifier>
</item>
<item>
<title>Spontaneous Coronary Artery Dissection in a Healthy Man With Non-ST Elevation Myocardial Infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38568656/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Apr 3. doi: 10.1001/jamacardio.2024.0381. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38568656/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38568656</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0381>10.1001/jamacardio.2024.0381</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38568656</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Chayakrit Krittanawong</dc:creator>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Louai Razzouk</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Spontaneous Coronary Artery Dissection in a Healthy Man With Non-ST Elevation Myocardial Infarction</dc:title>
<dc:identifier>pmid:38568656</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0381</dc:identifier>
</item>
<item>
<title>Risk of Cardiac Arrhythmias Among Climbers on Mount Everest</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38568602/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION AND RELEVANCE: In this study, more than 1 in 3 healthy individuals experienced cardiac arrhythmia during the climb of Mount Everest, thereby confirming the association between exposure to high altitude and incidence of cardiac arrhythmia. Future studies should explore the potential implications of these rhythm disturbances.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Apr 3. doi: 10.1001/jamacardio.2024.0364. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Arterial hypoxemia, electrolyte imbalances, and periodic breathing increase the vulnerability to cardiac arrhythmia at altitude.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To explore the incidence of tachyarrhythmias and bradyarrhythmias in healthy individuals at high altitudes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study involved healthy individuals at altitude (8849 m) on Mount Everest, Nepal. Recruitment occurred from January 25 to May 9, 2023, and data analysis took place from June to July 2023.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURE: All study participants underwent 12-lead electrocardiogram, transthoracic echocardiography, and exercise stress testing before and ambulatory rhythm recording both before and during the expedition.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOME: The incidence of a composite of supraventricular (>;30 seconds) and ventricular (>;3 beats) tachyarrhythmia and bradyarrhythmia (sinoatrial arrest, second- or third-degree atrioventricular block).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of the 41 individuals recruited, 100% were male, and the mean (SD) age was 33.6 (8.9) years. On baseline investigations, there were no signs of exertional ischemia, wall motion abnormality, or cardiac arrhythmia in any of the participants. Among 34 individuals reaching basecamp at 5300 m, 32 participants climbed to 7900 m or higher, and 14 reached the summit of Mount Everest. A total of 45 primary end point-relevant events were recorded in 13 individuals (38.2%). Forty-three bradyarrhythmic events were documented in 13 individuals (38.2%) and 2 ventricular tachycardias in 2 individuals (5.9%). Nine arrhythmias (20%) in 5 participants occurred when climbers were using supplemental bottled oxygen, whereas 36 events (80%) in 11 participants occurred at lower altitudes when no supplemental bottled oxygen was used. The proportion of individuals with arrhythmia remained stable across levels of increasing altitude, while event rates per 24 hours numerically increased between 5300 m (0.16 per 24 hours) and 7300 m (0.37 per 24 hours) before decreasing again at higher altitudes, where supplemental oxygen was used. None of the study participants reported dizziness or syncope.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION AND RELEVANCE: In this study, more than 1 in 3 healthy individuals experienced cardiac arrhythmia during the climb of Mount Everest, thereby confirming the association between exposure to high altitude and incidence of cardiac arrhythmia. Future studies should explore the potential implications of these rhythm disturbances.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38568602/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38568602</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0364>10.1001/jamacardio.2024.0364</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38568602</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Kunjang Sherpa</dc:creator>
<dc:creator>Pasang Phurba Sherpa</dc:creator>
<dc:creator>Tendi Sherpa</dc:creator>
<dc:creator>Martina Rothenbühler</dc:creator>
<dc:creator>Christoph Ryffel</dc:creator>
<dc:creator>Dhukpa Sherpa</dc:creator>
<dc:creator>Dawa Renji Sherpa</dc:creator>
<dc:creator>Ojaswee Sherchand</dc:creator>
<dc:creator>Oskar Galuszka</dc:creator>
<dc:creator>Chrisoula Dernektsi</dc:creator>
<dc:creator>Tobias Reichlin</dc:creator>
<dc:creator>Thomas Pilgrim</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Risk of Cardiac Arrhythmias Among Climbers on Mount Everest</dc:title>
<dc:identifier>pmid:38568602</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0364</dc:identifier>
</item>
<item>
<title>Weekly journal scan: it takes two for acute stroke</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38568212/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 3:ehae166. doi: 10.1093/eurheartj/ehae166. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38568212/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38568212</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae166>10.1093/eurheartj/ehae166</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38568212</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly journal scan: it takes two for acute stroke</dc:title>
<dc:identifier>pmid:38568212</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae166</dc:identifier>
</item>
<item>
<title>Syphilis and cardiovascular risk: a Taiwanese registry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38568209/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study demonstrates that patients with syphilis have a higher risk of cardiovascular events and all-cause mortality compared with those without syphilis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093/eurheartj/ehae183. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Studies on the impact of syphilis on the cardiovascular system in large populations are limited. This study investigated the effects of syphilis on cardiovascular outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Medical records from 2010 to 2015 were retrieved from the Taiwan National Health Insurance Research Database, linked to the Notifiable Infectious Diseases database from the Taiwan Centers for Disease Control. Patients with syphilis were identified, excluding those with missing information, under 20 years of age, or with a history of human immunodeficiency virus infection, acute myocardial infarction, heart failure, aortic regurgitation, replacement of the aortic valve, aneurysm and/or dissection of the aorta, atrial fibrillation, ischaemic stroke, haemorrhagic stroke, and venous thromboembolism. Primary outcomes included new-onset acute myocardial infarction, heart failure, aortic regurgitation, aneurysm and dissection of the aorta, atrial fibrillation, ischaemic stroke, haemorrhagic stroke, venous thromboembolism, cardiovascular death, and all-cause mortality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 28 796 patients with syphilis were identified from 2010 to 2015. After exclusions and frequency matching, 20 601 syphilis patients and 20 601 non-syphilis patients were analysed. The relative rate (RR) was utilized in the analysis, as the competing risk of death was not considered. Compared with patients without syphilis, patients with syphilis had increased risks of acute myocardial infarction (RR 38%, 95% confidence interval [CI] 1.19-1.60, P &lt; .001), heart failure (RR 88%, 95% CI 1.64-2.14, P &lt; .001), aortic regurgitation (RR 81%, 95% CI 1.18-2.75, P = .006), atrial fibrillation (RR 45%, 95% CI 1.20-1.76, P &lt; .001), ischaemic stroke (RR 68%, 95% CI 1.52-1.87, P &lt; .001), haemorrhagic stroke (RR 114%, 95% CI 1.74-2.64, P &lt; .001), venous thromboembolism (RR 67%, 95% CI 1.23-2.26, P = .001), cardiovascular death (RR 155%, 95% CI 2.11-3.08, P &lt; .001), and all-cause death (RR 196%, 95% CI 2.74-3.19, P &lt; .001) but not for aneurysm and dissection of the aorta.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study demonstrates that patients with syphilis have a higher risk of cardiovascular events and all-cause mortality compared with those without syphilis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38568209/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38568209</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae183>10.1093/eurheartj/ehae183</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38568209</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Victor Chien-Chia Wu</dc:creator>
<dc:creator>Jih-Kai Yeh</dc:creator>
<dc:creator>Shao-Wei Chen</dc:creator>
<dc:creator>Chia-Ling Wu</dc:creator>
<dc:creator>Yu-Sheng Lin</dc:creator>
<dc:creator>Michael Wu</dc:creator>
<dc:creator>Kai-Che Wei</dc:creator>
<dc:creator>Pao-Hsien Chu</dc:creator>
<dc:creator>Shang-Hung Chang</dc:creator>
<dc:creator>Yu-Tung Huang</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Syphilis and cardiovascular risk: a Taiwanese registry</dc:title>
<dc:identifier>pmid:38568209</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae183</dc:identifier>
</item>
<item>
<title>Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38567497/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>Guideline-directed medical therapies and guideline-directed nonpharmacological therapies improve quality of life and survival in patients with heart failure (HF), but eligible patients, particularly women and individuals from underrepresented racial and ethnic groups, are often not treated with these therapies. Implementation science uses evidence-based theories and frameworks to identify strategies that facilitate uptake of evidence to improve health. In this scientific statement, we provide an...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 3. doi: 10.1161/CIR.0000000000001231. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Guideline-directed medical therapies and guideline-directed nonpharmacological therapies improve quality of life and survival in patients with heart failure (HF), but eligible patients, particularly women and individuals from underrepresented racial and ethnic groups, are often not treated with these therapies. Implementation science uses evidence-based theories and frameworks to identify strategies that facilitate uptake of evidence to improve health. In this scientific statement, we provide an overview of implementation trials in HF, assess their use of conceptual frameworks and health equity principles, and provide pragmatic guidance for equity in HF. Overall, behavioral nudges, multidisciplinary care, and digital health strategies increased uptake of therapies in HF effectively but did not include equity goals. Few HF studies focused on achieving equity in HF by engaging stakeholders, quantifying barriers and facilitators to HF therapies, developing strategies for equity informed by theory or frameworks, evaluating implementation measures for equity, and titrating strategies for equity. Among these HF equity studies, feasibility was established in using various educational strategies to promote organizational change and equitable care. A couple include ongoing randomized controlled pragmatic trials for HF equity. There is great need for additional HF implementation trials designed to promote delivery of equitable guideline-directed therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38567497/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38567497</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001231>10.1161/CIR.0000000000001231</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38567497</guid>
<pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Khadijah Breathett</dc:creator>
<dc:creator>Sabra Lewsey</dc:creator>
<dc:creator>Nicholas K Brownell</dc:creator>
<dc:creator>Kendra Enright</dc:creator>
<dc:creator>Lorraine S Evangelista</dc:creator>
<dc:creator>Nasrien E Ibrahim</dc:creator>
<dc:creator>Jose Iturrizaga</dc:creator>
<dc:creator>Daniel D Matlock</dc:creator>
<dc:creator>Modele O Ogunniyi</dc:creator>
<dc:creator>Madeline R Sterling</dc:creator>
<dc:creator>Harriette G C Van Spall</dc:creator>
<dc:creator>American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; and Council on Quality of Care and Outcomes Research</dc:creator>
<dc:date>2024-04-03</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38567497</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001231</dc:identifier>
</item>
<item>
<title>Interventional thrombus modification in STEMI</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38565957/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 2. doi: 10.1038/s41569-024-01020-2. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38565957/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38565957</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01020-2>10.1038/s41569-024-01020-2</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38565957</guid>
<pubDate>Tue, 02 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jason L Walsh</dc:creator>
<dc:creator>Rafail A Kotronias</dc:creator>
<dc:creator>Adrian P Banning</dc:creator>
<dc:creator>Giovanni Luigi De Maria</dc:creator>
<dc:date>2024-04-02</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Interventional thrombus modification in STEMI</dc:title>
<dc:identifier>pmid:38565957</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01020-2</dc:identifier>
</item>
<item>
<title>Small extracellular vesicles from the infarcted heart can promote tumour growth</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38565956/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 2. doi: 10.1038/s41569-024-01022-0. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38565956/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38565956</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01022-0>10.1038/s41569-024-01022-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38565956</guid>
<pubDate>Tue, 02 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Karina Huynh</dc:creator>
<dc:date>2024-04-02</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Small extracellular vesicles from the infarcted heart can promote tumour growth</dc:title>
<dc:identifier>pmid:38565956</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01022-0</dc:identifier>
</item>
<item>
<title>Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8&lt;sup>;+&lt;/sup>; T cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38565142/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>Taurine is used to bolster immunity, but its effects on antitumor immunity are unclear. Here, we report that cancer-related taurine consumption causes T cell exhaustion and tumor progression. The taurine transporter SLC6A6 is correlated with aggressiveness and poor outcomes in multiple cancers. SLC6A6-mediated taurine uptake promotes the malignant behaviors of tumor cells but also increases the survival and effector function of CD8^(+) T cells. Tumor cells outcompete CD8^(+) T cells for taurine...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 28:S0092-8674(24)00303-9. doi: 10.1016/j.cell.2024.03.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Taurine is used to bolster immunity, but its effects on antitumor immunity are unclear. Here, we report that cancer-related taurine consumption causes T cell exhaustion and tumor progression. The taurine transporter SLC6A6 is correlated with aggressiveness and poor outcomes in multiple cancers. SLC6A6-mediated taurine uptake promotes the malignant behaviors of tumor cells but also increases the survival and effector function of CD8<sup>+</sup> T cells. Tumor cells outcompete CD8<sup>+</sup> T cells for taurine by overexpressing SLC6A6, which induces T cell death and malfunction, thereby fueling tumor progression. Mechanistically, taurine deficiency in CD8<sup>+</sup> T cells increases ER stress, promoting ATF4 transcription in a PERK-JAK1-STAT3 signaling-dependent manner. Increased ATF4 transactivates multiple immune checkpoint genes and induces T cell exhaustion. In gastric cancer, we identify a chemotherapy-induced SP1-SLC6A6 regulatory axis. Our findings suggest that tumoral-SLC6A6-mediated taurine deficiency promotes immune evasion and that taurine supplementation reinvigorates exhausted CD8<sup>+</sup> T cells and increases the efficacy of cancer therapies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38565142/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38565142</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.011>10.1016/j.cell.2024.03.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38565142</guid>
<pubDate>Tue, 02 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Tianyu Cao</dc:creator>
<dc:creator>Wenyao Zhang</dc:creator>
<dc:creator>Qi Wang</dc:creator>
<dc:creator>Chen Wang</dc:creator>
<dc:creator>Wanqi Ma</dc:creator>
<dc:creator>Cangang Zhang</dc:creator>
<dc:creator>Minghui Ge</dc:creator>
<dc:creator>Miaomiao Tian</dc:creator>
<dc:creator>Jia Yu</dc:creator>
<dc:creator>Anjun Jiao</dc:creator>
<dc:creator>Liang Wang</dc:creator>
<dc:creator>Manjiao Liu</dc:creator>
<dc:creator>Pei Wang</dc:creator>
<dc:creator>Zhiyu Guo</dc:creator>
<dc:creator>Yun Zhou</dc:creator>
<dc:creator>Shuyi Chen</dc:creator>
<dc:creator>Wen Yin</dc:creator>
<dc:creator>Jing Yi</dc:creator>
<dc:creator>Hao Guo</dc:creator>
<dc:creator>Hua Han</dc:creator>
<dc:creator>Baojun Zhang</dc:creator>
<dc:creator>Kaichun Wu</dc:creator>
<dc:creator>Daiming Fan</dc:creator>
<dc:creator>Xin Wang</dc:creator>
<dc:creator>Yongzhan Nie</dc:creator>
<dc:creator>Yuanyuan Lu</dc:creator>
<dc:creator>Xiaodi Zhao</dc:creator>
<dc:date>2024-04-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8&lt;sup>;+&lt;/sup>; T cells</dc:title>
<dc:identifier>pmid:38565142</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.011</dc:identifier>
</item>
<item>
<title>Endothelial PTP1B Deletion Promotes VWF Exocytosis and Venous Thromboinflammation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38563147/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our findings show that endothelial PTP1B deletion promotes venous thromboinflammation by enhancing SNAP23 phosphorylation, endothelial VWF exocytosis, and neutrophil recruitment.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 2. doi: 10.1161/CIRCRESAHA.124.324214. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Endothelial activation promotes the release of procoagulant extracellular vesicles and inflammatory mediators from specialized storage granules. Endothelial membrane exocytosis is controlled by phosphorylation. We hypothesized that the absence of PTP1B (protein tyrosine phosphatase 1B) in endothelial cells promotes venous thromboinflammation by triggering endothelial membrane fusion and exocytosis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Mice with inducible endothelial deletion of PTP1B (End.PTP1B-KO) underwent inferior vena cava ligation to induce stenosis and venous thrombosis. Primary endothelial cells from transgenic mice and human umbilical vein endothelial cells were used for mechanistic studies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Vascular ultrasound and histology showed significantly larger venous thrombi containing higher numbers of Ly6G (lymphocyte antigen 6 family member G)-positive neutrophils in mice with endothelial PTP1B deletion, and intravital microscopy confirmed the more pronounced neutrophil recruitment following inferior vena cava ligation. RT<sup>2</sup> PCR profiler array and immunocytochemistry analysis revealed increased endothelial activation and adhesion molecule expression in primary End.PTP1B-KO endothelial cells, including CD62P (P-selectin) and VWF (von Willebrand factor). Pretreatment with the NF-κB (nuclear factor kappa B) kinase inhibitor BAY11-7082, antibodies neutralizing CD162 (P-selectin glycoprotein ligand-1) or VWF, or arginylglycylaspartic acid integrin-blocking peptides abolished the neutrophil adhesion to End.PTP1B-KO endothelial cells in vitro. Circulating levels of annexin V<sup>+</sup> procoagulant endothelial CD62E<sup>+</sup> (E-selectin) and neutrophil (Ly6G<sup>+</sup>) extracellular vesicles were also elevated in End.PTP1B-KO mice after inferior vena cava ligation. Higher plasma MPO (myeloperoxidase) and Cit-H3 (citrullinated histone-3) levels and neutrophil elastase activity indicated neutrophil activation and extracellular trap formation. Infusion of End.PTP1B-KO extracellular vesicles into C57BL/6J wild-type mice most prominently enhanced the recruitment of endogenous neutrophils, and this response was blunted in VWF-deficient mice or by VWF-blocking antibodies. Reduced PTP1B binding and tyrosine dephosphorylation of SNAP23 (synaptosome-associated protein 23) resulting in increased VWF exocytosis and neutrophil adhesion were identified as mechanisms, all of which could be restored by NF-κB kinase inhibition using BAY11-7082.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our findings show that endothelial PTP1B deletion promotes venous thromboinflammation by enhancing SNAP23 phosphorylation, endothelial VWF exocytosis, and neutrophil recruitment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38563147/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38563147</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324214>10.1161/CIRCRESAHA.124.324214</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38563147</guid>
<pubDate>Tue, 02 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Konstantinos Zifkos</dc:creator>
<dc:creator>Magdalena L Bochenek</dc:creator>
<dc:creator>Rajinikanth Gogiraju</dc:creator>
<dc:creator>Stephane Robert</dc:creator>
<dc:creator>Denise Pedrosa</dc:creator>
<dc:creator>Klytaimnistra Kiouptsi</dc:creator>
<dc:creator>Kateryna Moiko</dc:creator>
<dc:creator>Mathias Wagner</dc:creator>
<dc:creator>Felix Mahfoud</dc:creator>
<dc:creator>Philippe Poncelet</dc:creator>
<dc:creator>Thomas Münzel</dc:creator>
<dc:creator>Wolfram Ruf</dc:creator>
<dc:creator>Christoph Reinhardt</dc:creator>
<dc:creator>Laurence Panicot-Dubois</dc:creator>
<dc:creator>Christophe Dubois</dc:creator>
<dc:creator>Katrin Schäfer</dc:creator>
<dc:date>2024-04-02</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial PTP1B Deletion Promotes VWF Exocytosis and Venous Thromboinflammation</dc:title>
<dc:identifier>pmid:38563147</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324214</dc:identifier>
</item>
<item>
<title>Association Between Chest Compression Pause Duration and Survival After Pediatric In-Hospital Cardiac Arrest</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38563137/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Each 5-second increment in longest CC pause duration during pediatric in-hospital cardiac arrest was associated with lower chance of survival with favorable neurological outcome, survival to hospital discharge, and return of spontaneous circulation. Any CC pause >;10 seconds or >;20 seconds and number of pauses >;10 seconds and >;20 seconds were significantly associated with lower adjusted probability of return of spontaneous circulation, but not survival or neurological outcomes.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2. doi: 10.1161/CIRCULATIONAHA.123.066882. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The association between chest compression (CC) pause duration and pediatric in-hospital cardiac arrest survival outcomes is unknown. The American Heart Association has recommended minimizing pauses in CC in children to &lt;10 seconds, without supportive evidence. We hypothesized that longer maximum CC pause durations are associated with worse survival and neurologicalal outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this cohort study of index pediatric in-hospital cardiac arrests reported in pediRES-Q (Quality of Pediatric Resuscitation in a Multicenter Collaborative) from July of 2015 through December of 2021, we analyzed the association in 5-second increments of the longest CC pause duration for each event with survival and favorable neurological outcome (Pediatric Cerebral Performance Category ≤3 or no change from baseline). Secondary exposures included having any pause >;10 seconds or >;20 seconds and number of pauses >;10 seconds and >;20 seconds per 2 minutes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We identified 562 index in-hospital cardiac arrests (median [Q1, Q3] age 2.9 years [0.6, 10.0], 43% female, 13% shockable rhythm). Median length of the longest CC pause for each event was 29.8 seconds (11.5, 63.1). After adjustment for confounders, each 5-second increment in the longest CC pause duration was associated with a 3% lower relative risk of survival with favorable neurological outcome (absolute risk reduction, 0.97 [95% CI, 0.95-0.99]; <i>P</i>=0.02). Longest CC pause duration was also associated with survival to hospital discharge (absolute risk reduction, 0.98 [95% CI, 0.96-0.99]; <i>P</i>=0.01) and return of spontaneous circulation (absolute risk reduction, 0.93 [95% CI, 0.91-0.94]; <i>P</i>&lt;0.001). Secondary outcomes of any pause >;10 seconds or >;20 seconds and number of CC pauses >;10 seconds and >;20 seconds were each significantly associated with lower absolute risk reduction of return of spontaneous circulation, but not survival or neurological outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Each 5-second increment in longest CC pause duration during pediatric in-hospital cardiac arrest was associated with lower chance of survival with favorable neurological outcome, survival to hospital discharge, and return of spontaneous circulation. Any CC pause >;10 seconds or >;20 seconds and number of pauses >;10 seconds and >;20 seconds were significantly associated with lower adjusted probability of return of spontaneous circulation, but not survival or neurological outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38563137/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38563137</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066882>10.1161/CIRCULATIONAHA.123.066882</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38563137</guid>
<pubDate>Tue, 02 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Kasper G Lauridsen</dc:creator>
<dc:creator>Ryan W Morgan</dc:creator>
<dc:creator>Robert A Berg</dc:creator>
<dc:creator>Dana E Niles</dc:creator>
<dc:creator>Monica E Kleinman</dc:creator>
<dc:creator>Xuemei Zhang</dc:creator>
<dc:creator>Heather Griffis</dc:creator>
<dc:creator>Jimena Del Castillo</dc:creator>
<dc:creator>Sophie Skellett</dc:creator>
<dc:creator>Javier J Lasa</dc:creator>
<dc:creator>Tia T Raymond</dc:creator>
<dc:creator>Robert M Sutton</dc:creator>
<dc:creator>Vinay M Nadkarni</dc:creator>
<dc:creator>pediRES-Q Investigators</dc:creator>
<dc:date>2024-04-02</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Association Between Chest Compression Pause Duration and Survival After Pediatric In-Hospital Cardiac Arrest</dc:title>
<dc:identifier>pmid:38563137</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066882</dc:identifier>
</item>
<item>
<title>Age-Dependent RGS5 Loss in Pericytes Induces Cardiac Dysfunction and Fibrosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38563133/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our results have identified RGS5 as a crucial regulator of pericyte function during cardiac aging. The deletion of RGS5 causes cardiac dysfunction and induces myocardial fibrosis, one of the hallmarks of cardiac aging.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 2. doi: 10.1161/CIRCRESAHA.123.324183. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Pericytes are capillary-associated mural cells involved in the maintenance and stability of the vascular network. Although aging is one of the main risk factors for cardiovascular disease, the consequences of aging on cardiac pericytes are unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this study, we have combined single-nucleus RNA sequencing and histological analysis to determine the effects of aging on cardiac pericytes. Furthermore, we have conducted in vivo and in vitro analysis of RGS5 (regulator of G-protein signaling 5) loss of function and finally have performed pericytes-fibroblasts coculture studies to understand the effect of RGS5 deletion in pericytes on the neighboring fibroblasts.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Aging reduced the pericyte area and capillary coverage in the murine heart. Single-nucleus RNA sequencing analysis further revealed that the expression of <i>Rgs5</i> was reduced in cardiac pericytes from aged mice. In vivo and in vitro studies showed that the deletion of RGS5 impaired cardiac function, induced fibrosis, and morphological changes in pericytes characterized by a profibrotic gene expression signature and the expression of different ECM (extracellular matrix) components and growth factors, for example, <i>TGFB2</i> and <i>PDGFB</i>. Indeed, culturing fibroblasts with the supernatant of RGS5-deficient pericytes induced their activation as evidenced by the increased expression of αSMA (alpha smooth muscle actin) in a TGFβ (transforming growth factor beta)2-dependent mechanism.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our results have identified RGS5 as a crucial regulator of pericyte function during cardiac aging. The deletion of RGS5 causes cardiac dysfunction and induces myocardial fibrosis, one of the hallmarks of cardiac aging.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38563133/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38563133</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.324183>10.1161/CIRCRESAHA.123.324183</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38563133</guid>
<pubDate>Tue, 02 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Anita Tamiato</dc:creator>
<dc:creator>Lukas S Tombor</dc:creator>
<dc:creator>Ariane Fischer</dc:creator>
<dc:creator>Marion Muhly-Reinholz</dc:creator>
<dc:creator>Leah Rebecca Vanicek</dc:creator>
<dc:creator>Büşra Nur Toğru</dc:creator>
<dc:creator>Jessica Neitz</dc:creator>
<dc:creator>Simone Franziska Glaser</dc:creator>
<dc:creator>Maximilian Merten</dc:creator>
<dc:creator>David Rodriguez Morales</dc:creator>
<dc:creator>Jeonghyeon Kwon</dc:creator>
<dc:creator>Stephan Klatt</dc:creator>
<dc:creator>Bianca Schumacher</dc:creator>
<dc:creator>Stefan Günther</dc:creator>
<dc:creator>Wesley T Abplanalp</dc:creator>
<dc:creator>David John</dc:creator>
<dc:creator>Ingrid Fleming</dc:creator>
<dc:creator>Nina Wettschureck</dc:creator>
<dc:creator>Stefanie Dimmeler</dc:creator>
<dc:creator>Guillermo Luxán</dc:creator>
<dc:date>2024-04-02</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Age-Dependent RGS5 Loss in Pericytes Induces Cardiac Dysfunction and Fibrosis</dc:title>
<dc:identifier>pmid:38563133</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.324183</dc:identifier>
</item>
<item>
<title>JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38561163/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Mar 30:S0735-1097(24)06820-7. doi: 10.1016/j.jacc.2024.03.414. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38561163/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38561163</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.414>10.1016/j.jacc.2024.03.414</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38561163</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Pedro R Moreno</dc:creator>
<dc:creator>Valentin Fuster</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction</dc:title>
<dc:identifier>pmid:38561163</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.414</dc:identifier>
</item>
<item>
<title>Focus on device innovation in interventional cardiology and on trials in cardiovascular prevention</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38558243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 1;45(13):1089-1093. doi: 10.1093/eurheartj/ehae180.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38558243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38558243</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae180>10.1093/eurheartj/ehae180</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38558243</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on device innovation in interventional cardiology and on trials in cardiovascular prevention</dc:title>
<dc:identifier>pmid:38558243</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae180</dc:identifier>
</item>
<item>
<title>Fifty years of percutaneous transluminal angioplasty</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38558170/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 1:ehae145. doi: 10.1093/eurheartj/ehae145. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38558170/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38558170</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae145>10.1093/eurheartj/ehae145</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38558170</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Marco Roffi</dc:creator>
<dc:creator>Bernhard Meier</dc:creator>
<dc:creator>Augusto Gallino</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Fifty years of percutaneous transluminal angioplasty</dc:title>
<dc:identifier>pmid:38558170</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae145</dc:identifier>
</item>
<item>
<title>Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38558097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093/eurheartj/ehae138. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38558097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38558097</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae138>10.1093/eurheartj/ehae138</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38558097</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation</dc:title>
<dc:identifier>pmid:38558097</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae138</dc:identifier>
</item>
<item>
<title>Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557127/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1087-1089. doi: 10.1161/CIRCULATIONAHA.123.067916. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557127/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38557127</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067916>10.1161/CIRCULATIONAHA.123.067916</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557127</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Akiko Maehara</dc:creator>
<dc:creator>Yoichiro Sugizaki</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?</dc:title>
<dc:identifier>pmid:38557127</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067916</dc:identifier>
</item>
<item>
<title>Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the Progression of Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557126/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):e1066. doi: 10.1161/CIR.0000000000001235. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557126/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38557126</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001235>10.1161/CIR.0000000000001235</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557126</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the Progression of Heart Failure</dc:title>
<dc:identifier>pmid:38557126</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001235</dc:identifier>
</item>
<item>
<title>Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart Failure Subtypes: A Liquid Biopsy Approach</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557125/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1147-1149. doi: 10.1161/CIRCULATIONAHA.123.065513. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557125/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38557125</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10987042/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">PMC10987042</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065513>10.1161/CIRCULATIONAHA.123.065513</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557125</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Priyanka Gokulnath</dc:creator>
<dc:creator>Michail Spanos</dc:creator>
<dc:creator>H Immo Lehmann</dc:creator>
<dc:creator>Quanhu Sheng</dc:creator>
<dc:creator>Rodosthenis Rodosthenous</dc:creator>
<dc:creator>Mark Chaffin</dc:creator>
<dc:creator>Dimitrios Varrias</dc:creator>
<dc:creator>Emeli Chatterjee</dc:creator>
<dc:creator>Elizabeth Hutchins</dc:creator>
<dc:creator>Guoping Li</dc:creator>
<dc:creator>George Daaboul</dc:creator>
<dc:creator>Farhan Rana</dc:creator>
<dc:creator>Ashley Mingyi Wang</dc:creator>
<dc:creator>Kendall Van Keuren-Jensen</dc:creator>
<dc:creator>Patrick T Ellinor</dc:creator>
<dc:creator>Ravi Shah</dc:creator>
<dc:creator>Saumya Das</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart Failure Subtypes: A Liquid Biopsy Approach</dc:title>
<dc:identifier>pmid:38557125</dc:identifier>
<dc:identifier>pmc:PMC10987042</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065513</dc:identifier>
</item>
<item>
<title>Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557124/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240403203928&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1059-1061. doi: 10.1161/CIRCULATIONAHA.123.066984. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557124/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240403203928&v=2.18.0.post9+e462414">38557124</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066984>10.1161/CIRCULATIONAHA.123.066984</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557124</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Sumeet S Chugh</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators</dc:title>
<dc:identifier>pmid:38557124</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066984</dc:identifier>
</item>





























</channel>
</rss>